TITomoaki Ishigami

Tomoaki Ishigami

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tomoaki Ishigami has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Hisao Ochiai

    From Yokohama City University, Internal Medicine II, Yokohama City, Japan

    1 shared publication
  • Izumi Kobayashi

    From Yokohama City University, Internal Medicine II, Yokohama City, Japan

    1 shared publication
  • Kiyoshi Hibi

    From Yokohama City University, Internal Medicine II, Yokohama City, Japan

    1 shared publication
  • Kouichi Tamura

    From Yokohama City University, Internal Medicine II, Yokohama City, Japan

    1 shared publication
  • Minoru Kihara

    From Yokohama City University, Internal Medicine II, Yokohama City, Japan

    1 shared publication
  • Satoshi Umemura

    From Yokohama City University, Internal Medicine II, Yokohama City, Japan

    1 shared publication

Latest Publications

  • Angiotensinogen Gene Polymorphism Near Transcription Start Site and Blood Pressure

    by Tomoaki Ishigami, Kouichi Tamura, Takayuki Fujita, Izumi Kobayashi, Kiyoshi Hibi, Minoru Kihara, Yoshiyuki Toya, Hisao Ochiai, Satoshi Umemura

    —Molecular variants of the angiotensinogen gene, a key component of the renin-angiotensin system, are considered genetic risk factors for primary hypertension. A relation between the angiotensinogen gene locus and hypertension has been found in whites, Japanese, and African Caribbeans but not in Chinese. The lack of a consistent association between M235T polymorphism at exon 2 and hypertension has suggested that another site in linkage disequilibrium with M235T is the causal mutation. We studied the relations among plasma angiotensinogen concentrations, blood pressure, related clinical variables, and mutations of the 5′ upstream core promoter region of the human angiotensinogen gene in 274 subjects recruited from our outpatient clinic. We confirmed that plasma angiotensinogen concentration was significantly correlated with A−20C mutation and percent body fat and found that systolic and diastolic blood pressures were significantly correlated with G−6A and T+68C mutations. These results suggest that mutations near the transcription start site may be associated with increased blood pressure.